Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral Ulodesine Added to Allopurinol

NCT01265264 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

279

Enrollment

INDUSTRY

Sponsor class

Conditions

Gout
Hyperuricemia
Arthritis
Joint Disease

Interventions

DRUG: ulodesine
DRUG: Placebo

Sponsor

BioCryst Pharmaceuticals